Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Clinical trial NCT01306929 · COMPLETED
Trial details
- NCT number
- NCT01306929
- Sponsor
- Prilenia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-24
- Primary completion
- 2018-01-05
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.